Industry insiders continue to spar over Waxman-Hatch Act
Debate between brand and generic drug companies contues to rage over whether the Waxman-Hatch Act should be overhauled.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Recent Videos
Related Content
